Chronic Obstructive Pulmonary Disease (COPD) Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2033

 In 2023, the global Chronic Obstructive Pulmonary Disease (COPD) Market the global Chronic Obstructive Pulmonary Disease (COPD) market is expected to be worth US$ 21.58 billion. With rising alcohol consumption, the overall demand for Chronic Obstructive Pulmonary Disease (COPD) is expected to rise at a CAGR of 4.4% between 2023 and 2033, reaching around US$ 33.19 billion by 2033.

According to Future Market Insights, the Chronic Obstructive Pulmonary Disease (COPD) market is expected to grow during the analysis period, owing to an increase in patient population as a result of a significant rise in asthma incidence and prevalence.

According to a World Health Organization (WHO) factsheet from 2021, asthma is a major noncommunicable disease (NCD) that affects both children and adults. In 2019, it affected an estimated 262 million people worldwide and killed 461,000 people.

The major market players’ business strategies include massive investments in asthma drug research, as well as strategic collaborations such as mergers and acquisitions. As a result, the aforementioned factors are expected to accelerate the growth of COPD.

For in-depth insights, Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16215

FMI, in its business report, elaborates the historical and current scenario of the global Chronic Obstructive Pulmonary Disease (COPD) market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Chronic Obstructive Pulmonary Disease (COPD) Market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Chronic Obstructive Pulmonary Disease (COPD) Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Chronic Obstructive Pulmonary Disease (COPD) market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Chronic Obstructive Pulmonary Disease (COPD) market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Chronic Obstructive Pulmonary Disease (COPD) market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-16215

Chronic Obstructive Pulmonary Disease (COPD) Market: Segmentation

Valuable information covered in the FMI’s Chronic Obstructive Pulmonary Disease (COPD) market report has been segregated into key segments and sub-segments.

Chronic Obstructive Pulmonary Disease (COPD) Market by Drug Class:

  • Combination Therapy
  • Bronchodilators
  • Corticosteroids
  • Phosphodiesterase Type 4 Inhibitor
  • Mucokinetics
  • Others

Chronic Obstructive Pulmonary Disease (COPD) Market by Type:

  • Chronic Bronchitis
  • Emphysema

Chronic Obstructive Pulmonary Disease (COPD) Market by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Comments

Post a Comment

Popular posts from this blog

Cardboard Flask Market Insights By Type, Industry, Application & End-User | FMI

 Beverage industry which is growing continuously has led to developments and innovations in the cardboard flask market. Countries that have high consumption of tea and coffee such as the USA, United Kingdom, China, Japan & India might impact the demand for cardboard flask. Cardboard flasks might not be predominant when it comes to the sale of these hot beverages in the brick and mortar store but E-commerce has hiked the demand for cardboard flask. The convenience and ease of ordering the hot beverages at their workplace and homes with advent of digitalization in developing countries such as India and China is likely to augment the demand for the cardboard flask market. Compared to its counterpart which is a traditional flask which were used by the brand owners to deliver the beverage to its customers, the cardboard flask provides more pros since its cuts down the cost of collecting and cleaning them. Thus, this is likely to positively impact the growth of the cardboard flask ma...
Read more

Radiopharmaceuticals Market: Worldwide Industry Analysis and New Market Opportunities Explored to 2032

  As per Future Market Insights (FMI), driven by rising cases of cancer and cardiovascular diseases,  radiopharmaceutical market  registered steady year-on-year growth Future Market Insights (FMI) predicted that the market for radiopharmaceuticals would be valued US$ 6.2 billion in 2022. The market for radiopharmaceuticals is expected to grow at a value CAGR of 4.3% between 2022 and 2032, reaching US$ 9.5 billion. Increasing preference of non-invasive medical therapies and production of radioisotopes for the treatment is another factor that will stabilize the growth of radiopharmaceuticals market. Based on this, FMI projects the market is poised to expand at over  4.66% CAGR  during the forecast period of 2021 and 2031. Government initiatives and research activities undertaken to develop advanced radioisotopes for the treatment of cancer and to develop novel therapeutics will boost the demand. Also, introduction of novel technologies such as Positron Emission Te...
Read more

Voice Assistants Market Research Report 2022 – Global Forecast till 2032

 The rising popularity of smartphones coupled with the increasing demand for sophisticated assistive technology will assure considerable growth opportunities for the voice assistant market during the forecast period of 2022-2032. The market for voice assistants is predicted to expand at a CAGR of 19% and reach US$ 4,329.0 million in 2022. By 2032, it is anticipated that the market would grow to US$ 24,588 Million. In addition, the rise in activities such as data collection through mobile devices, unified communications, and wireless network strengthens the growth trajectory to a considerable extent. Recent Development Automating repetitive tasks is an important benefit offered by voice assistant applications. While routine tasks are carried out by voice assistant applications, humans can perform other tasks that are more important. Thus, introducing voice assistants not only enhances consumer experience but also increases the productivity levels of an organization or a business. Th...
Read more